-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...

-The United Nations Some 15 million babies worldwide – more than one in ten births – are born too early, according to a new United Nations-backed report, released today, which calls for steps such as ensuring the requisite medicines and equipment and training health staff to promote child survival. “All newborns are vulnerable, but preterm babies are acutely so,” says Secretary General Ban Ki-moon, who wrote the foreword to the report, entitled...

* 11 percent of babies born premature in 2010, 1.1 million died * Experts estimate 75 percent could be saved * U.S. rate at 12 pct, fueled by later births, fertility treatments NEW YORK, May 2 (Reuters) - The world's developed countries have seen their average rate of premature births double to 6 percent since 1995, despite efforts to reduce the phenomenon, according to a report released on Wednesday. Worldwide, 15 million of the...

A campaign to help the elderly spend the evening of their lives with dignity and without want is being launched by Pension Parishad with a dharna in Delhi from May 7th to May 11th 2012 at Jantar Mantar, New Delhi. The idea is straight and simple, and is something whose time has come. Just read on and reach the venue for more information and interviews with the campaign participants.   “One...